<div id="readability-page-1">DexCom, Inc. (NASDAQ:DXCM) is one of the stocks on Jim Cramer’s radar recently. A caller asked if they should buy, sell, or hold the stock during the lightning round. In response, Cramer said: “You know, it’s too rich a stock, and I do think the GLP-1s are going to have such a dramatic effect on […]</div>

德康医疗

<p>德康医疗（DexCom, Inc.）（NASDAQ:DXCM）是吉姆·克莱默最近关注的股票之一。在快速问答环节中，一位来电者询问是否应该买入、卖出或持有该股票。对此，克莱默表示：“你知道，这是一只价格过高的股票，我确实认为 GLP-1 类药物将会对……产生如此显著的影响。”</p>

Jim Cramer 对德康医疗的评价：“这只股票定价过高”